Right Job, Wrong Tool: A Commentary on Designing Clinical Trials for Ebola Virus Disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Bioethics

• Publication date

  2015-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/15265161.2015.1010018PMID 25856596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selecting the Right Tool For the Job

  2015cited by this paper
• Ebola in Freetown area, Sierra Leone--a case study of 581 patients.

  2015cited by this paper
• Randomised controlled trials for Ebola: practical and ethical issues.

  2014cited by this paper
• Clinical development success rates for investigational drugs

  2014cited by this paper
• Evaluating Ebola therapies--the case for RCTs.

  2014cited by this paper
• Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

  2013cited by this paper
• Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial

  2011cited by this paper
• A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS

  2008cited by this paper

• More Than One Way to Measure? A Casuistic Approach to Cancer Clinical Trials

  2018cites this paper
• Communitarian societies and public engagement in public health

  2017cites this paper
• Methodological considerations in clinical trials for new MDR-TB treatment regimens.

  2016cites this paper
• The Ebola clinical trials: a precedent for research ethics in disasters

  2016cites this paper
• The Perfect Must Not Overwhelm the Good: Response to Open Peer Commentaries on “Selecting the Right Tool For the Job”

  2015cites this paper